Document is current
Any future updates will be listed below
-
Authors
Ussher, John R. https://orcid.org/0000-0001-9574-5707
Drucker, Daniel J. https://orcid.org/0000-0001-6688-8127
- License Information
-
More Information
Article History
Accepted: 17 February 2023
First Online: 28 March 2023
Competing interests
: D.J.D. is a consultant to Altimmune, Amgen, Kallyope, Merck, Novo Nordisk and Pfizer. Mount Sinai Hospital has received funding for investigator-initiated preclinical studies from Novo Nordisk and Pfizer. J.R.U. declares no competing interests.
